Promote Sponsor
verified SJR 1,105 · Q2 • database Scopus / SJR & Web of Science indexed
Journal of Diabetes
United States · Wiley-Blackwell
workspace_premium Q2 — Endocrinology, Diabetes and Metabolism lock Subscription Unclaimed

Journal of Diabetes

Journal of Diabetes is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism with an H index of 61. It has a price of 2395 €. It has an SJR impact factor of 1,105 and it has a best quartile of Q2. It has an SJR impact factor of 1,105.

ISSN: 1753-0393
Editorial: Wiley-Blackwell
Category: Endocrinology, Diabetes and Metabolism
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
1,105 Q2
H-index 61
Tasa de Aceptación pie_chart
31%
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
2.395 € Subscription
Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

1,105

H-index

61

Docs (year)

169

Docs 3y

320

Total refs

7004

Cites 3y

1014

Citable 3y

237

Cites/Doc 2y

3.46

Ref/Doc

41.44

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Joint associations of insomnia and sleep duration with prevalent diabetes: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

View more

White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients: Prevalence and target organ damage

View more

Troubling ethical questions from gestational diabetes trial

View more

Sodium-glucose cotransporter 2 inhibitor-associated diabetic ketoacidosis: Report of two cases with hyperglycemic ketoacidosis in type 1 diabetes

View more

SLEep among diabetic patients and their GlycaEmic control (SLEDGE): A pilot observational study

View more

Simple non-laboratory- and laboratory-based risk assessment algorithms and nomogram for detecting undiagnosed diabetes mellitus

View more

Shortage of energy intake rather than protein intake is associated with sarcopenia in elderly patients with type 2 diabetes: A cross-sectional study of the KAMOGAWA-DM cohort

View more

Structured tool to improve clinical outcomes of type 2 diabetes mellitus patients: A randomized controlled trial

View more

Metabolic Management Center: An innovation project for the management of metabolic diseases and complications in China

View more

Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study

View more

Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: A pilot prospective randomized trial

View more

Journal of Diabetes NEWS

View more
SHOW MORE ARTICLES

Metformin use during pregnancy: Is it really safe?

View more

Is there a relationship between hepatitis B surface antibody status and diabetes?

View more

Is diabetes an independent risk factor for in-hospital complications after a stroke?

View more

Intramuscular injection of soluble receptor for advanced glycation endproducts expression vector prevents the development of streptozotocin-induced diabetes mellitus in rats on high fat diet

View more

Impact of glucose load in an oral glucose tolerance test on urinary albumin excretion varies with 2-h glucose levels

View more

Hypoglycemia in diabetes: The dark side of diabetes treatment. A patient-centered review

View more

Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia

View more

Heart failure prevention with sodium-glucose cotransporter 2 inhibitors

View more

Gut hormones and the brain*

View more

Glucose represses PPARagene expression via AMP-activated protein kinase but not via p38 mitogen-activated protein kinase in the pancreatic beta-cell

View more

Gestational Diabetes Mellitus:current knowledge and unmet needs

View more

Genetic markers of type 2 diabetes: Progress in genome-wide association studies and clinical application for risk prediction

View more

FAQS